Ebastine
- Generic Name
- Ebastine
- Drug Type
- Small Molecule
- Chemical Formula
- C32H39NO2
- CAS Number
- 90729-43-4
- Unique Ingredient Identifier
- TQD7Q784P1
Overview
Ebastine is under investigation for the treatment of Irritable Bowel Syndrome (IBS). Ebastine has been investigated for the treatment of Urticaria.
Background
Ebastine is under investigation for the treatment of Irritable Bowel Syndrome (IBS). Ebastine has been investigated for the treatment of Urticaria.
Indication
用于伴有或不伴有过敏性结膜炎的过敏性鼻炎（季节性和常年性）。慢性特发性荨麻疹的对症治疗。
Associated Conditions
- Allergic Rhinitis (AR)
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
KESTINE TABLET 10 mg
Manufacturer:INDUSTRIAS FARMACEUTICAS ALMIRALL (IFA) S.A.-2nd Site
Form:TABLET, FILM COATED
Strength:10.00mg
Online:Yes
Approved: 1997/07/31
Approval:SIN09435P
KESTINE FILM-COATED TABLET 20MG
Manufacturer:Industrias Farmaceuticas Almirall. S.A. (IFA)
Form:TABLET, FILM COATED
Strength:20.0mg
Online:Yes
Approved: 2019/03/12
Approval:SIN15644P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath